Multiple sclerosis findings in the spinal cord

Expert Review of Neurotherapeutics

Volumn 7, Issue 9, 2007, Pages 1203-1211

  Edwards, L J ^a   Tench, C R ^a   Gilmore, C P ^a   Evangelou, N ^b   Constantinescu, C S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Atrophy; Demyelination; MRI; Multiple sclerosis; Spinal cord

Indexed keywords

BRAIN DAMAGE; DEMYELINATING DISEASE; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SPINAL CORD BIOPSY;

HUMANS; MULTIPLE SCLEROSIS; NEURAL PATHWAYS; SPINAL CORD;

EID: 34548818498     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.7.9.1203     Document Type: Review

References (89)

1. Ramirez-Lassepas M, Tulloch JW, Quinones MR, Snyder BD. Acute radicular pain as a presenting symptom in multiple sclerosis. Arch. Neurol. 49(3), 255-258 (1992).
2. Kraus JA, Stuper BK, Berlit P. Multiple sclerosis presenting with a Brown-Sequard syndrome. J. Neurol. Sci. 156(1), 112-113 (1998).
3. Ozaki I, Suzuki C, Baba M, Matsunaga M. Multiple sclerosis manifesting as a Brown-Sequard syndrome. Eur. J. Neurol. 10(2), 190-191 (2003).
4. Sotgiu S, Sechi G, Pugliatti M et al. Multiple sclerosis associated with syringomyelia. J. Neurol. Neurosurg. Psychiatr. 67(2), 248 (1999).
5. Iwasaki Y, Ikeda K, Ichikawa Y, Igarashi O. Multiple sclerosis and syrinx formation. Acta Neurol. Scand. 101(5), 346 (2000).
6. Matsuda M, Tabata K, Miki J et al. Multiple sclerosis with secondary syringomyelia. An autopsy report. J. Neurol. Sci. 184(2), 189-196 (2001).
7. Ransohoff RM, Whitman GJ, Weinstein MA. Noncommunicating syringomyelia in multiple sclerosis: detection by magnetic resonance imaging. Neurology 40(4), 718-721 (1990).
8. Solaro C, Uccelli A, Gentile R et al. Multiple sclerosis and non-communicating syringomyelia: a casual association or linked diseases? Acta Neurol. Scand. 100(4), 270-273 (1999).
9. Waziri A, Vonsattel JP, Kaiser MG, Anderson RC. Expansile, enhancing cervical cord lesion with an associated syrinx secondary to demyelination. Case report and review of the literature. J. Neurosurg. 6(1), 52-56 (2007).
10. Trop I, Bourgouin PM, Lapierre Y et al. Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity. AJNR Am. J. Neuroradiol. 19(6), 1025-1033 (1998).
11. Thorpe JW, Kidd D, Moseley IF et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46(2), 373-378 (1996).
12. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58(6), 840-846 (2005).
13. Bot JC, Barkhof F, Polman CH et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62(2), 226-233 (2004).
14. Thorpe JW, Kidd D, Moseley IF et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119(Pt 3), 709-714 (1996).
15. Bot JC, Barkhof F, Lycklama a Nijeholt G et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223(1), 46-56 (2002).
16. Brex PA, Leary SM, O'Riordan JI et al. Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 70(4), 544-547 (2001).
17. Dalton CM, Brex PA, Miszkiel KA et al. Spinal cord MRI in clinically isolated optic neuritis. J. Neurol. Neurosurg. Psychiatr. 74(11), 1577-1580 (2003).
18. Cordonnier C, de Seze J, Breteau G et al. Prospective study of patients presenting with acute partial transverse myelopathy. J. Neurol. 250(12), 1447-1452 (2003).
19. Steiner I, Feir G, Soffer D, Pleet AB, Abramsky O. Chronic progressive myelopathy: its relation to the spinal progressive form of multiple sclerosis. Acta Neurol. Scand. 77(2), 152-157 (1988).
20. Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch. Neurol. 50(5), 532-535 (1993).
21. de Seze J, Stojkovic T, Gauvrit JY et al. Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates. J. Neurol. 248(4), 297-303 (2001).
22. Vaithianathar L, Tench CR, Morgan PS, Constantinescu CS. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis - a quantitative T1 relaxation time mapping approach. J. Neurol. 250(3), 307-315 (2003).
23. Ukkonen M, Dastidar P, Heinonen T, Laasonen E, Elovaara I. Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability. Eur. J. Neurol. 10(6), 663-669 (2003).
24. Tartaglino LM, Friedman DP, Flanders AE et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195(3), 725-732 (1995).
25. Kidd D, Thorpe JW, Thompson AJ et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43(12), 2632-2637 (1993).
26. Rot U, Mesec A. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis. Clin. Neurol. Neurosurg. 108(3), 271-274 (2006).
27. Lin X, Blumhardt LD, Constantinescu CS. The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study. Acta Neurol. Scand. 108(6), 401-406 (2003).
28. Mann R, Constantinescu C, Tench C. Upper cervical spinal cord cross sectional area in relapsing remitting multiple sclerosis: application of a new technique for measuring cross sectional area on magnetic resonance images. J. Magn. Reson. Imaging 26(1), 61-65 (2007).
29. Rashid W, Davies GR, Chard DT et al. Upper cervical cord area in early relapsingremitting multiple sclerosis: cross-sectional study of factors influencing cord size. J. Magn. Reson. Imaging 23(4), 473-476 (2006).
30. Bieniek M, Altmann DR, Davies GR et al. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 77(9), 1036-1039 (2006).
31. Stevenson VL, Leary SM, Losseff NA et al. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 51(1), 234-238 (1998).
32. Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon-β-1a (Rebif) treatment trial. J. Neurol. Neurosurg. Psychiatr. 74(8), 1090-1094 (2003).
33. Rashid W, Davies GR, Chard DT et al. Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J. Neurol. Neurosurg. Psychiatr. 77(1), 51-55 (2006).
34. Lycklama a Nijeholt GJ, Barkhof F, Scheltens P et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am. J. Neuroradiol. 18(6), 1041-1048 (1997).
35. Losseff NA, Webb SL, O'Riordan JI et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119(Pt 3), 701-708 (1996).
36. Edwards SG, Gong QY, Liu C et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 122(Pt 2), 291-301 (1999).
37. Rovaris M, Bozzali M, Santuccio G et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 124(Pt 12), 2540-2549 (2001).
38. Kidd D, Thorpe JW, Kendall BE et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 60(1), 15-19 (1996).
39. Stevenson VL, Miller DH, Leary SM et al. One year follow up study of primary and transitional progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 68(6), 713-718 (2000).
40. Ingle GT, Stevenson VL, Miller DH, Thompson AJ. Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 126(Pt 11), 2528-2536 (2003).
41. Filippi M, Bozzali M. A conventional and magnetization transfer MRI study of the cervial cord in patients with MS. Neurology 54(1), 207-213 (2000).
42. Lycklama a Nijeholt GJ, Castelijns JA. Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability. J. Neuroimaging 10(2), 67-72 (2000).
43. Liu C, Edwards S, Gong Q, Roberts N, Blumhardt LD. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 66(3), 323-330 (1999).
44. Bot JC, Blezer EL, Kamphorst W et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 233(2), 531-540 (2004).
45. Bashir K, Whitaker JN. Clinical and laboratory features of primary progressive and secondary progressive MS. Neurology 53(4), 765-771 (1999).
46. Tench CR, Morgan PS, Jaspan T, Auer DP, Constantinescu CS. Spinal cord imaging in multiple sclerosis. J. Neuroimaging 15(Suppl. 4), S94-S102 (2005).
47. Lin X, Tench CR, Evangelou N, Jaspan T, Constantinescu CS. Measurement of spinal cord atrophy in multiple sclerosis. J. Neuroimaging 14(Suppl. 3), S20-S26 (2004).
48. Rocca MA, Hickman SJ, Bo L et al. Imaging spinal cord damage in multiple sclerosis. J. Neuroimaging 15(4), 297-304 (2005).
49. Lycklama G, Thompson A, Filippi M et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol. 2(9), 555-562 (2003).
50. Silver NC, Good CD, Sormani MP et al. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis. J. Neurol. 248(3), 215-224 (2001).
51. Rocca MA, Mastronardo G, Horsfield MA et al. Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR Am. J. Neuroradiol. 20(9), 1710-1716 (1999).
52. Hittmair K, Mallek R, Prayer D, Schindler EG, Kollegger H. Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. AJNR Am. J. Neuroradiol. 17(8), 1555-1565 (1996).
53. Tench CR, Morgan PS, Constantinescu CS. Measurement of cervical spinal cord cross-sectional area by MRI using edge detection and partial volume correction. J. Magn. Reson. Imaging 21(3), 197-203 (2005).
54. Leary SM, Miller DH, Stevenson VL et al. Interferon-β-1a in primary progressive MS: an exploratory, randomized, controlled trial. Neurology 60(1), 44-51 (2003).
55. Weinshenker BG. Neuromyelitis optica is distinct from multiple sclerosis. Arch. Neurol. 64(6), 899-901 (2007).
56. Roach ES. Is neuromyelitis optica a distinct entity? Arch. Neurol. 64(6), 906 (2007).
57. Frohman EM, Kerr D. Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters". Arch. Neurol. 64(6), 903-905 (2007).
58. Galetta SL, Bennett J. Neuromyelitis optica is a variant of multiple sclerosis. Arch. Neurol. 64(6), 901-903 (2007).
59. Filippi M, Rocca MA, Moiola L et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology 53(8), 1705-1710 (1999).
60. Minagar A, Alexander JS, Fowler MR, Long AC, Kelley RE. Devic disease: clinical course, pathophysiology, and management. Pathophysiology 9(1), 33 (2002).
61. de Seze J, Stojkovic T, Ferriby D et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J. Neurol. Sci. 197(1-2), 57-61 (2002).
62. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 68(8), 603-605 (2007).
63. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann. Neurol. 34(2), 162-168 (1993).
64. Lucchinetti CF, Mandler RN, McGavern D et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125(Pt 7), 1450-1461 (2002).
65. Misu T, Fujihara K, Kakita A et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130(Pt 5), 1224-1234 (2007).
66. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2(2), 117-127 (2003).
67. Weinshenker BG, Wingerchuk DM, Nakashima I, Fujihara K, Lennon VA. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol. 5(2), 110-111 (2006).
68. Fukazawa T, Tashiro K, Hamada T et al. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern. Med. 31(3), 349-352 (1992).
69. Fukazawa T, Kikuchi S, Miyagishi R et al. CSF pleocytosis and expansion of spinal lesions in Japanese multiple sclerosis with special reference to the new diagnostic criteria. J. Neurol. 252(7), 824-829 (2005).
70. Kira J, Kanai T, Nishimura Y et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann. Neurol. 40(4), 569-574 (1996).
71. Misu T, Fujihara K, Nakashima I et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 125(Pt 11), 2460-2468 (2002).
72. Warabi Y, Matsumoto Y, Hayashi H. Interferon-β-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J. Neurol. Sci. 252(1), 57-61 (2007).
73. Weinstock-Guttman B, Ramanathan M, Lincoff N et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch. Neurol. 63(7), 957-963 (2006).
74. Cree BA, Lamb S, Morgan K et al. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64(7), 1270-1272 (2005).
75. Nakashima I, Fujihara K, Miyazawa I et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J. Neurol. Neurosurg. Psychiatr. 77(9), 1073-1075 (2006).
76. Takahashi T, Fujihara K, Nakashima I et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130(Pt 5), 1235-1243 (2007).
77. Roemer SF, Parisi JE, Lennon VA et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130(Pt 5), 1194-1205 (2007).
78. Matsuoka T, Matsushita T, Kawano Y et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130(Pt 5), 1206-1223 (2007).
79. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10), 1485-1489 (2006).
80. Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol. Appl. Neurobiol. 4(2), 151-162 (1978).
81. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 48(6), 893-901 (2000).
82. DeLuca GC, Williams K, Evangelou N, Ebers GC, Esiri MM. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 129(Pt 6), 1507-1516 (2006).
83. DeLuca GC, Ebers GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 127(Pt 5), 1009-1018 (2004).
84. Gilmore CP, Bo L, Owens T et al. Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol. 16(3), 202-208 (2006).
85. Gilmore CP, DeLuca GC, Bo L et al. Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch. Neurol. 62(12), 1859-1862 (2005).
86. Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol. Appl. Neurobiol. 25(6), 459-467 (1999).
87. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123(Pt 2), 308-317 (2000).
88. Evangelou N, DeLuca GC, Owens T, Esiri MM. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 128(Pt 1), 29-34 (2005).
89. Nijeholt GJ, Bergers E, Kamphorst W et al. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 124(Pt 1), 154-166 (2001).